Combined Military Hospital (CMH)
Multan, Punjab Province, 60000, Pakistan
NCT Number: NCT07458022
Role of Magnesium in Depressive Disorder
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Phase 2
Multan, Punjab Province, 60000, Pakistan
Because of the significant role that magnesium serves in mood regulation, the goal of this study is to evaluate the impact of starting the therapy of major depressive disorder with a combination of SSRI and Mg, as well as SSRI alone.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients of above 18 years diagnosed with DSM who had MDD and receiving SSRI alone and SSRI plus magnesium.
Exclusion criteria
Individuals who recently underwent treatment with electroconvulsive therapy, have a history of epilepsy or other severe neurological problems, have experienced a head injury, are cognitively impaired, and have comorbid conditions such as liver, renal, cardiovascular, neurological, or endocrine, or respiratory problems, or are pregnant or nursing mothers
Impact of combination of SSRI and Magnesium in Major Depressive Disorder
Only SSRI will be given
Time frame: Four Weeks
Change in severity of depressive symptoms, measured by the difference in mean scores on the Beck Depression Inventory-II (BDI-II) from baseline to 4 weeks post-intervention
University of Child Health Sciences and Children's Hospital, Lahore
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07281352
Major Depressive Diorder
Los Angeles, California, United States
View Trial DetailsNCT07369115
Early Life Trauma, Major Depressive Diorder
Austin, Texas, United States
View Trial DetailsNCT07362511
Behavior, Behavioral Symptoms
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT06641726
Bipolar Disorder, Bipolar Disorder (BD)
Oxford, United Kingdom
View Trial Details